Skip to content

Announcements

DateTitle
20 Feb 24, 10:59Apollon Formularies Plc - CANCER CELL KILLING RESULTS PUBLISHED IN THE PEER-REVIEWED ONLINE JOURNAL OF COMPLEMENTARY AND ALTERNATIVE MEDICINE (OJCAM)

View

05 Feb 24, 07:00Apollon Formularies Plc - Issue of Equity

View

02 Jan 24, 08:18Apollon Formularies Plc - Result of AGM

View

05 Dec 23, 11:59Apollon Formularies Plc - Notice of AGM

View

21 Nov 23, 11:51Apollon Formularies Plc - Sproutly and Apollon Conclude Due Diligence, Paving Way for Asset Purchase Agreement

View

29 Sep 23, 07:00Apollon Formularies Plc - Interim Results for the 6 Months ended 30 June 2023

View

19 Sep 23, 09:18Apollon Formularies Plc - Execution of Binding LOI with Sproutly Canada, Inc.

View

03 Aug 23, 10:50Apollon Formularies Plc - Resignation of Non-Executive Director

View

02 Aug 23, 12:18Apollon Formularies Plc - Update on Global Hemp Group

View

24 Jul 23, 11:00Apollon Formularies Plc - Apollon grants an Exclusive Licence Agreement to PureCann, South Africa

View

30 Jun 23, 17:32Apollon Formularies - Final Results for the Year Ended 31 December 2022

View

10 May 23, 17:05Apollon Formularies Plc - Update on Global Hemp Group

View

11 Apr 23, 14:00Apollon Formularies Plc - Result of General Meeting

View

21 Mar 23, 12:00Apollon Formularies Plc - 28 day due diligence extension for Asset sale

View

15 Mar 23, 07:00Apollon Formularies - Notice of General Meeting

View

12 Jan 23, 07:00Apollon Formularies - Execution of Binding Letter of Intent with GHG

View

30 Dec 22, 12:37Apollon Formularies - Result of AGM

View

02 Dec 22, 07:00Apollon Formularies - Notice of AGM

View

30 Sep 22, 09:50Apollon Formularies - Interim Results

View

13 Sep 22, 07:00Apollon Formularies - Directors’ Dealing

View


Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2024. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal